Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2011-07-26
2011-07-26
Fronda, Christian (Department: 1652)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C435S379000, C435S383000, C435S404000
Reexamination Certificate
active
07985408
ABSTRACT:
The present invention relates to a method for culturing tenocytes. In particular the present invention relates to a method for culturing tenocytes comprising the step of incubating tenocytes in a culture medium comprising insulin or functional derivative.
REFERENCES:
patent: 4939239 (1990-07-01), Matsuhashi et al.
patent: 6368298 (2002-04-01), Beretta et al.
patent: 6569172 (2003-05-01), Asculai et al.
patent: 2002/0173806 (2002-11-01), Gianetti et al.
patent: 2003/0144197 (2003-07-01), Zheng et al.
patent: 2004/0037812 (2004-02-01), Giannetti
patent: 2004/0078077 (2004-04-01), Binette et al.
patent: 2004/0267362 (2004-12-01), Hwang et al.
patent: 2005/0177249 (2005-08-01), Kladaki et al.
patent: 2005/0226856 (2005-10-01), Ahlfors
Abrahamsson, S.O. et al., “Differential Effects of Insulin-Like Growth Factor-I on Matrix and DNA Synthesis in Various Regions and Types of Rabbit Tendons,” J. Ortho. Res., 1996, 14, 370-376.
Abrahamsson, S.O.J., “Similar Effects of Recombinant Human Insulin-Like Growth Factor-I and II on Cellular Activities in Flexor-Tendons of Young Rabbits: Experimental Studies in Vitro,” Ortho. Res., 1996, 15, 256-262.
Abrahamsson, S.O. et al., “Recombinant human insulin-like growth factor-1 stimulates in vitro matrix synthesis and cell proliferation in rabbit flexor tendon,” Journal of Orthopaedic Research, 1991, 9(4), 495-502.
Abrahamsson, S.O. et al., “Long-Term Explant Culture of Rabbit Flexor Tendon: Effects of Recombinant Human Insulin-Like Growth factor-I and Serum on Matrix Metabolism,” Journal of Orthopaedic Research, 1991, 9, 503-515.
Anitua, E. et al., “Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture,” J. Ortho Res., 2005, 23, 281-286.
Bourcier, T. et al., “Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone,” Investigative Ophthalmology & Visual Science, 2000, 41(13), 4133-4141.
Buren, J. et al., “Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase protein kinase B in primary cultured rat adipocytes,” European Journal of Endocrinology, 2002, 146, 419-429.
Calleja, C. et al., “The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor,” Nat. Med., Jan. 1998, 4, 92-96.
Cao, Y et al., Bridging Tendon Defects Using Autologous Tenocyte Engineered Tendon in a Hen Model, Plast. Reconstr. Surg., 2002, 110, 1280-1289.
Chan et al., “Insulin-through the ages: Phylogeny of a growth promoting and metabolic regulatory hormone,” American Zoologist, Apr. 2000, accessible at http://www.findarticies.com/p/articles/mi—qa3746/is—200004/ai—n8899929.
Dahlgren et al., “Effects of β-aminopropionitrile on equine tendon metabolism in vitro and on effects of insulin-like growth factor-I on matrix production by equine tenocytes,” AJVR, 2001, 62(10), 1557-1562.
Fernandez-Figares, I. et al., “The role of insulin, glucagon, dexamethasone, and leptin in the regulation of ketogenesis and glycogen storage in primary cultures of porcine hepatocytes prepared from 60kg pigs,” Domestic Animal Endocrinology, 2004, 27, 125-140.
Ganguly, R. et al., “Absolute requirement of glucocorticoid for expression of the casein gene in the presence of prolactin,” Proceedings of the National Academy of Sciences USA, 1980, 77(10), 6003-6006.
Gauger, A. et al., “A low-serum medium for tendon cells: effects of growth factors on tendon cell growth and collagen production,” In Vitro Cellular & Developmental Biology, 1985, 21(5), 291-296.
Grandhi, A. et al., “A comparative pharmacological investigation of Ashwagandha and Ginseng,” J. Ethnopharmacol., 1994, 44, 131-135.
Kang & Kang, “Ideal Concentration of Growth Factors in Rabbit's Flexor Tendon Culture,” Yonsei Med. J., 1999, 40(1), 26-29.
Kuroyanagi & Sato, Allergy, 1966, 15, 67-75.
Marsh, D.G., “Preparation and Properties of ‘Allergoids’ Derived from Native Pollen Allergens by Mild Formalin Treatment,” Int. Arch. Of Allergy and Appl. Immunol., 1971, 41, 199-215.
Schulze-Tanzil, G. et al., “Cultivation of human tenocytes in high-density culture,” Histochemistry and Cell Biology, 2004, 122, 219-228.
Tarr, G.E., “Manual Edman Sequencing System,” in: Methods of Protein Micro-characterisation, J.E. Silver ed., Humana Press, Clifton, N.J., 155-194 (1986).
Torricelli, P. et al., “Effects of systemic glucocorticoid administration on tenocytes,” Biomedicine and Pharmacotherapy, 2006, 60, 380-385.
Wong, M.W.N. et al., “Glucocorticoids suppress proteoglycan production by human tenocytes,” Acta Orthopaedica, 2005, 76(6), 927-931.
Youssef, J. et al., “Glucocorticoid-like effects of antihepatocarcinogen Rotenone are mediated via enhanced serum corticosterone levels: Molecular Fitting and Receptor Activation Studies,” J. Carcinogenesis, 2003, 2.
Fronda Christian
The University of Western Australia
Woodcock & Washburn LLP
LandOfFree
Tenocyte cell culturing method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tenocyte cell culturing method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tenocyte cell culturing method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2685341